Global Trajectory of the Life Sciences and Analysis Tools Market, 2020-2022 and 2027 –

DUBLIN – (BUSINESS CHP) – The report “Life Science Tools – Global Market Trajectory and Analysis” has been added to’s supply.

The global market for life sciences tools will reach $ 183.8 billion by 2027

Against the backdrop of the crisis with COVID-19, the global market for life science tools, valued at $ 89.4 billion in 2020, is expected to reach a revised amount of $ 183.8 billion by 2027, increasing with CAGR of 10.8% during the analysis period 2020-2027

Cell biology, one of the segments analyzed in the report, is expected to grow by 9.9% CAGR to reach $ 71.3 billion by the end of the analysis period.

After an early analysis of the business impact of the pandemic and the resulting economic crisis, growth in the Genomics segment was adjusted to a revised 10.9% CAGR for the next 7 years. This segment currently accounts for 20.6% of the global market for life science tools.

The United States represents more than 37.2% of the global market size in 2020, while China is projected to grow by 16.2% CAGR for the period 2020-2027.

The market for life science tools in the United States is estimated at $ 33.3 billion in 2020. The country currently has a share of 37.21% of the world market. China, the world’s second-largest economy, is expected to reach a market size of $ 20.3 billion in 2027, lagging behind the CAGR by 16.2% by 2027.

Other notable geographic markets include Japan and Canada, each forecasting growth of 8.4% and 10.1% respectively in the period 2020-2027. Within Europe, Germany is expected to grow by approximately 10% CAGR, while the rest part of the European market (as defined in the study) will reach $ 20.3 billion by 2027

Proteomics Segment Corners with a share of 22.4% in 2020

In the global proteomics segment, the United States, Canada, Japan, China and Europe will account for 12.4% of the CAGR calculated for this segment. These regional markets, which represent a combined market size of $ 16.6 billion in 2020, will reach an estimated $ 37.6 billion by the end of the analysis period.

China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India and South Korea, the market in the Asia-Pacific region is expected to reach $ 20.3 billion by 2027.

What’s new for 2022?

  • Global competitiveness and market shares of key competitors

  • Market presence in many geographies – Strong / Active / Niche / Trivial

  • Online interactive peer-to-peer collaborative custom updates

  • Access to the publisher’s digital archives and research platform

  • Free updates for one year

Main topics covered:




  • Impact of COVID-19 on the life sciences sector

  • Competitive market presence – strong / active / niche / trivial for 33 players worldwide in 2022 (E)

  • Recent market activity

  • World brands

  • Tools for the science of life: a prelude

  • Market perspective

  • Cell biology holds a significant share of revenue

  • Intertwined factors with major implications for the field of life sciences and related tools


  • Abbott Laboratories Inc.

  • Agilent Technologies, Inc.

  • Becton, Dickinson and company

  • Bio-Rad Laboratories, Inc.

  • Bruker Corporation

  • Carl Zeiss AG

  • Eppendorf SE

  • F. Hoffmann-La Roche AG

  • Hitachi High-Tech Corporation

  • Illumina, Inc.

  • Merck KGaA

  • Oxford Instruments plc

  • PerkinElmer Inc.


  • Shimadzu Corporation

  • Thermo Fisher Scientific Inc.


  • Trends in the search for support in the life sciences research sector

  • 3D cell culture is transforming the life sciences industry

  • Growing demand for 3D cell culture in drug discovery

  • Use of 3D cell culture for regenerative medicine

  • Proteomics is emerging as an important research tool in the battle against COVID-19

  • The urgent need for diagnosis and therapy of COVID-19 emphasizes the dynamic role of proteomics

  • Proteomic profiling to accelerate drug detection

  • Proteomics in the foreground with the latest advances

  • Mass spectrometry (MS) expands the application of proteomics

  • AI and machine learning address the shortcomings of traditional equipment in effectively identifying protein models

  • mRNA technology is gaining spotlight in the life sciences

  • Innovations in instruments expand functionality and stimulate PCR adoption

  • Synoptic review of technical progress in quantitative PCR in recent years

  • Greater integration of genomic technologies in the development of new diagnostic tests

  • The next generation sequence stimulates market growth

  • Research and development remains vital in NGS

  • The need for large-scale analysis of NGS data is driving cloud bioinformatics services

  • Unicellular spatial biology technologies ready to emerge as an integral aspect of future laboratories

  • The increasing use of whole-genome sequencing is leading to the search for faster secondary analysis tools.

  • Rapid growth in the biopharmaceutical industry and growing investment in research and development to increase market prospects

  • Liquid chromatography stimulates the growth of new application markets

  • Innovative HPLC products inject new growth

  • The digital transformation of the life sciences sector is improving efficiency and productivity

  • Key initiators of the digital transformation in the life sciences

  • Rising spending on research and development in the pharmaceutical and biotechnology sectors provides opportunities

  • Technological developments and extensions of end-use applications to promote growth in mass spectrometry

  • Miniature mass spectroscopy tools are becoming popular

  • Increase health care costs to stimulate demand for life sciences tools




For more information on this report, visit

Leave a Comment

Your email address will not be published.